Site Content

---

2025-2026 CUREBOUND: Harnessing Tumor-Penetrating Peptides To Modulate The Pancreatic Tumor Immune Microenvironment. P.I. G. Botta and D. Hargreaves (Salk)

2025-2027 CUREBOUND: Translational Clinical Trial of Cemiplimab + Gemcitabine in SWI/SNF Altered Metastatic Pancreatic Cancer. P.I. G.Botta and D. Hargreaves (Salk)

2018-2024 NIH NCI LRP Grant: iRGD Reprogramming of Metabolically Suppressed Pancreatic Cancer; KYGF9753; P.I. G. Botta, MD/PhD 

2020-2021 Padres Pedal the Cause Grant: Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer; P.I. G. Botta and R. Evans (Salk Institute)

2019-2020 Conquer Cancer Foundation, Young Investigator Award (YIA) American Society of Clinical Oncology (ASCO) 

2016-2020 NIH KL2 Grant: Clinical and Translational Science Award Initiative 5KL2TR001112-02; P.I. E. Topol, MD/G. Botta, MD/PhD 

2018-2019 Scripps Pilot Grant Research and Education Award Patient Pancreatic Cancer T-cell sequencing

2018-2019 Genomic Pilot Award: Single Cell RNA Sequencing Sanford Burnham Prebys Medical Discovery InstituteMouse Pancreatic cancer T-cell sequencing 

2017-2019 Scripps Pilot Grant Research and Education Award Bone Marrow is Reservoir for Future Carcinoma Dissemination

2016-2019 Scripps Pilot Grant Research and Education Award in vivo Bioassay of Human Pancreatic Circulating Tumor Cells from Mice

2010-2014 NIH F30 Grant: Ruth L. Kirschstein National Research Service Awards  

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

F30DK088402-04; co-P.I. Peter Lelkes, PhD & Anil Rustgi, MD   

2013 Amadeo Bondi Fellowship  Biomedical Graduate Studies Program

Drexel University College of Medicine

Awarded to one Ph.D. student for excellence in research performance  

2006-2014 Drexel University College of Medicine MD/PhD Scholarship     

Biomedical Graduate Studies Program  for Dual Degree Candidates in the Basic Sciences   

2004  William W. Dawson Memorial Grant    Carnegie Mellon University